Phoenix Financial
TEVA icon

Phoenix Financial’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Phoenix Financial’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.69B Sell
42,625,947
-307,420
-0.7% -$11M 11.38% 1
2026
Q2 		$1.45B Buy
42,933,367
+155,953
+0.4% +$5.19M 9.94% 1
2026
Q1 		$1.29B Buy
42,777,414
+1,690,283
+4% +$54.4M 12.21% 1
2025
Q4 		$1.28B Sell
41,087,131
-208,113
-0.5% -$5.13M 13.9% 1
2025
Q3 		$834M Buy
41,295,244
+3,533,800
+9% +$62.1M 10.17% 1
2025
Q2 		$633M Buy
37,761,444
+10,296,872
+37% +$166M 8.35% 1
2025
Q1 		$422M Buy
27,464,572
+6,252,030
+29% +$112M 6.46% 1
2024
Q4 		$468M Sell
21,212,542
-1,349,134
-6% -$24.5M 6.38% 2
2024
Q3 		$407M Sell
22,561,676
-2,860,920
-11% -$50.1M 6.01% 2
2024
Q2 		$413M Sell
25,422,596
-9,159,191
-26% -$141M 6.29% 2
2024
Q1 		$488M Buy
34,581,787
+198,595
+0.6% +$2.5M 6.74% 2
2023
Q4 		$404M Sell
34,383,192
-98,500
-0.3% -$920K 6.69% 2
2023
Q3 		$352M Buy
34,481,692
+778,282
+2% +$7.25M 6.44% 2
2023
Q2 		$254M Buy
33,703,410
+11,569,608
+52% +$93.8M 5.19% 1
2023
Q1 		$196M Sell
22,133,802
-24,749
-0.1% -$245K 4.38% 2
2022
Q4 		$202M Buy
22,158,551
+1,327,471
+6% +$11.6M 3.91% 4
2022
Q3 		$163M Buy
20,831,080
+2,301,291
+12% +$20.3M 3.59% 4
2022
Q2 		$139M Buy
18,529,789
+1,830,388
+11% +$15.9M 2.85% 5
2022
Q1 		$157M Buy
16,699,401
+1,513,100
+10% +$12.6M 2.64% 4
2021
Q4 		$122M Buy
15,186,301
+1,015,500
+7% +$9.17M 2.01% 8
2021
Q3 		$138M Buy
14,170,801
+2,620,800
+23% +$24.5M 2.39% 5
2021
Q2 		$114M Sell
11,550,001
-26,132
-0.2% -$277K 2.18% 4
2021
Q1 		$134M Buy
11,576,133
+2,952,046
+34% +$33.9M 3.02% 2
2020
Q4 		$83.1M Sell
8,624,087
-2,527,589
-23% -$24.2M 2.23% 2
2020
Q3 		$94.7M Sell
11,151,676
-532,913
-5% -$5.64M 3.96% 1
2020
Q2 		$137M Buy
11,684,589
+355,220
+3% +$4.02M 5.8% 1
2020
Q1 		$99.3M Buy
11,329,369
+4,729,800
+72% +$48.5M 5.03% 1
2019
Q4 		$64.2M Buy
6,599,569
+1,371,737
+26% +$12.2M 2.68% 2
2019
Q3 		$34.3M Buy
+5,227,832
New +$40.1M 1.63% 7

Other funds holding TEVA

Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $16.3B AUM 54.64% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $21.3B AUM 44.31% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $5.74B AUM 42.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Y.D. More Investments
Y.D. More Investments Ramat Gan, Israel $3.47B AUM 82.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Sound Shore Management
Sound Shore Management Greenwich, Connecticut $3.2B AUM 19.02% 1-Year Est. Return
Todd Asset Management
Todd Asset Management Louisville, Kentucky $5.51B AUM 33.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Phoenix Financial's TEVA Position: Q3 2026 in Review

Phoenix Financial reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 0.72% in Q3 2026, selling an estimated $11M and leaving 42,625,947 shares worth $1.69B. The position accounts for 11.38% of the portfolio, ranked #1.

Phoenix Financial first reported a position in TEVA in Q3 2019 and has held it in 29 quarters since. 272 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Phoenix Financial held 42,625,947 shares of Teva Pharmaceutical Industries Limited worth $1.69B as of Q3 2026.
  • Phoenix Financial sold 307,420 Teva Pharmaceutical Industries Limited shares in Q3 2026, an estimated $11M.
  • Teva Pharmaceutical Industries Limited made up 11.38% of Phoenix Financial's portfolio in Q3 2026, its #1 holding.
  • Phoenix Financial first reported a position in Teva Pharmaceutical Industries Limited in Q3 2019 and has held it in 29 quarters since.
  • 272 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Phoenix Financial's 13F filing for Q3 2026, filed 9 Nov 2026.